Detalhe da pesquisa
1.
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.
J Clin Microbiol
; 59(7): e0083721, 2021 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33903166
2.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing.
J Clin Microbiol
; 59(2)2021 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33208477
3.
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
J Clin Microbiol
; 59(2)2021 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33139419
4.
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
J Infect Dis
; 222(12): 1974-1984, 2020 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32910175
5.
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen.
EBioMedicine
; 102: 105040, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38485563
6.
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.
Microbiol Spectr
; 12(1): e0328623, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38009954
7.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
JCI Insight
; 9(8)2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38483534
8.
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland.
Drug Alcohol Depend Rep
; 8: 100184, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37637232
9.
Early Treatment, Inflammation and Post-COVID Conditions.
medRxiv
; 2023 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36824860
10.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
medRxiv
; 2023 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37131659
11.
Early antibody treatment, inflammation, and risk of post-COVID conditions.
mBio
; 14(5): e0061823, 2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37724870
12.
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.
Lancet Microbe
; 4(9): e692-e703, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37659419
13.
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
medRxiv
; 2022 Feb 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35169815
14.
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for Real-Time Pandemic Surveillance.
Open Forum Infect Dis
; 9(5): ofac142, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35415200
15.
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
PLoS One
; 17(6): e0264298, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35679259
16.
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.
medRxiv
; 2021 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33880484
17.
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Status in Decedents Undergoing Forensic Postmortem Examination in Maryland, May 24 to June 30, 2020.
Open Forum Infect Dis
; 8(1): ofaa611, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33506069
18.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing.
medRxiv
; 2020 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32793916
19.
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers.
medRxiv
; 2020 Sep 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32908987
20.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions".
mBio
; 15(1): e0297923, 2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38095433